AIM
BSX icon

Acrospire Investment Management’s Boston Scientific BSX Stock Holding History

Acrospire Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,071
Closed -$141K – 209
2017
Q2 		$141K Buy
5,071
+3,100
+157% +$82.3K 0.13% 92
2017
Q1 		$49K Sell
1,971
-1,500
-43% -$36.5K 0.04% 972
2016
Q4 		$75K Sell
3,471
-2,329
-40% -$50.8K 0.03% 1121
2016
Q3 		$138K Sell
5,800
-700
-11% -$16.7K 0.09% 310
2016
Q2 		$152K Buy
6,500
+3,900
+150% +$84.4K 0.11% 188
2016
Q1 		$49K Buy
+2,600
New +$45.7K 0.03% 965

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Acrospire Investment Management's BSX Position: Q3 2017 in Review

Acrospire Investment Management sold out of Boston Scientific (BSX) in Q3 2017, closing a stake of 5,071 shares — an estimated $141K sold.

Acrospire Investment Management first reported a position in BSX in Q1 2016 and held it in 6 quarters. The position peaked at $152K in Q2 2016. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

  • Acrospire Investment Management reported no remaining Boston Scientific position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 5,071 Boston Scientific shares in Q3 2017, an estimated $141K.
  • Acrospire Investment Management first reported a position in Boston Scientific in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Boston Scientific position peaked at $152K in Q2 2016.
  • 547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.